Stefan K. Barta
-
- Lymphoma Diagnosis and Treatment 88
- Oncology top 2%
- CAR-T cell therapy research 55
- Viral-associated cancers and disorders 30
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 31
- Dermatology top 2%
- Cutaneous lymphoproliferative disorders research 25
- Immunology top 5%
- T-cell and Retrovirus Studies 13
-
- CNS Lymphoma Diagnosis and Treatment 8
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Yang LiuSandra P. Susanibar-AdaniyaCarlyn TanSaif Abdul-MajeedJakub SvobodaAriela NoyJoseph A. SparanoJeannette Y. Lee
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Stefan K. Barta
129 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Pathology and Forensic Medicine 1.1k
- Oncology 1.1k
- Genetics 341
- Dermatology 182
- Immunology 431
Countries citing papers authored by Stefan K. Barta
This map shows the geographic impact of Stefan K. Barta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan K. Barta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan K. Barta more than expected).
Fields of papers citing papers by Stefan K. Barta
This network shows the impact of papers produced by Stefan K. Barta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan K. Barta. The network helps show where Stefan K. Barta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan K. Barta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 3 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 20 | |
| 15 | 2020 | 97 | |
| 16 | 2019 | 19 | |
| 17 | 2017 | 4 | |
| 18 | 2011 | 69 | |
| 19 | 2011 | 62 | |
| 20 | 1999 | 60 |
About Stefan K. Barta
Stefan K. Barta is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 146 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (88 papers), CAR-T cell therapy research (55 papers), Chronic Lymphocytic Leukemia Research (31 papers), Viral-associated cancers and disorders (30 papers), Cutaneous lymphoproliferative disorders research (25 papers), T-cell and Retrovirus Studies (13 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Oncology (1.1k citations) and Genetics (341 citations). Stefan K. Barta has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Yang Liu, Sandra P. Susanibar-Adaniya, Carlyn Tan, Saif Abdul-Majeed, Jakub Svoboda, Ariela Noy, Joseph A. Sparano, Jeannette Y. Lee, Daniel J. Landsburg and Yasuhiro Oki. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Blood Advances and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.